These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9203677)

  • 1. Interleukin-8 and chemotactic activity of middle ear effusions.
    Storgaard M; Larsen K; Blegvad S; Nødgaard H; Ovesen T; Andersen PL; Obel N
    J Infect Dis; 1997 Feb; 175(2):474-7. PubMed ID: 9203677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 gene expression in middle ear effusions.
    Takeuchi K; Maesako K; Yuta A; Sakakura Y
    Ann Otol Rhinol Laryngol; 1994 May; 103(5 Pt 1):404-7. PubMed ID: 8179258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion.
    Nassif PS; Simpson SQ; Izzo AA; Nicklaus PJ
    Laryngoscope; 1997 Sep; 107(9):1223-7. PubMed ID: 9292607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8 in otitis media with effusion.
    Hotomi M; Samukawa T; Yamanaka N
    Acta Otolaryngol; 1994 Jul; 114(4):406-9. PubMed ID: 7976312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytological study and chemotactic activity in middle ear effusion.
    Somekawa Y; Yamanaka N; Shimoda K; Suzuki T; Kataura A
    Auris Nasus Larynx; 1985; 12 Suppl 1():S191-3. PubMed ID: 3835904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
    Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM
    Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid factor in otitis media with effusion.
    DeMaria TF; McGhee RB; Lim DJ
    Arch Otolaryngol; 1984 May; 110(5):279-80. PubMed ID: 6538783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.
    Zielnik-Jurkiewicz B; Stankiewicz-Szymczak W
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1369-78. PubMed ID: 26078091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotactic activity in middle ear effusions.
    Bernstein JM; Park BH
    Otolaryngol Head Neck Surg; 1981; 89(6):1007-12. PubMed ID: 6801579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization and phagocytosis of bacteria during various middle ear infections.
    Stenfors LE; Räisänen S
    Int J Pediatr Otorhinolaryngol; 1993 Aug; 27(2):137-45. PubMed ID: 8258481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study of proinflammatory cytokines and chemokines in the middle ear of acute otitis media due to Alloiococcus otitidis.
    Harimaya A; Fujii N; Himi T
    Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):677-80. PubMed ID: 19185927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin in middle ear effusions: in cases with persistent effusion after acute otitis media.
    Iino Y; Yuasa R; Kaneko Y; Takasaka T; Kawamoto K
    Auris Nasus Larynx; 1985; 12 Suppl 1():S94-6. PubMed ID: 3835949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble L-selectin and interleukin-8 in otitis media with effusion.
    Pospiech L; Jaworska M; Kubacka M
    Auris Nasus Larynx; 2000 Jul; 27(3):213-7. PubMed ID: 10808107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of middle ear effusion on neutrophil function.
    Shimizu T; Harada T; Hamaguchi Y; Majima Y; Sakakura Y
    Am J Otolaryngol; 1989; 10(2):132-7. PubMed ID: 2929881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions.
    Yellon RF; Doyle WJ; Whiteside TL; Diven WF; March AR; Fireman P
    Arch Otolaryngol Head Neck Surg; 1995 Aug; 121(8):865-9. PubMed ID: 7619411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vascular endothelial growth factor in pediatric otitis media with effusion.
    Sekiyama K; Ohori J; Matsune S; Kurono Y
    Auris Nasus Larynx; 2011 Jun; 38(3):319-24. PubMed ID: 21227609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular events in relation to bacteria-specific antibodies in middle ear effusion during acute otitis media.
    Karjalainen H
    Acta Otolaryngol; 1991; 111(4):750-5. PubMed ID: 1950538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion.
    DeMaria TF; Prior RB; Briggs BR; Lim DJ; Birck HG
    J Clin Microbiol; 1984 Jul; 20(1):15-7. PubMed ID: 6611350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does endotoxin trigger inflammation in otitis media with effusion?
    Schousboe LP; Ovesen T; Eckhardt L; Rasmussen LM; Pedersen CB
    Laryngoscope; 2001 Feb; 111(2):297-300. PubMed ID: 11210878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion.
    Kariya S; Okano M; Hattori H; Sugata Y; Matsumoto R; Fukushima K; Schachern PA; Cureoglu S; Paparella MM; Nishizaki K
    Otol Neurotol; 2006 Dec; 27(8):1089-93. PubMed ID: 16988618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.